Cargando…
Two cases of CRPC with BRCA mutation treated by olaparib after favorable response to cisplatin
INTRODUCTION: Several prostate cancers carry homologous recombination repair mutations that respond to olaparib. Because of the mechanism, the efficacy of platinum‐based therapy can be used to predict the efficacy of poly(adenosine diphosphate‐ribose) polymerase inhibitors such as olaparib. CASE PRE...
Autores principales: | Miyazawa, Yoshiyuki, Shimizu, Takanori, Sekine, Yoshitaka, Arai, Seiji, Ohtsu, Akira, Fujizuka, Yuji, Nomura, Masashi, Koike, Hidekazu, Matsui, Hiroshi, Suzuki, Kazuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807333/ https://www.ncbi.nlm.nih.gov/pubmed/36605692 http://dx.doi.org/10.1002/iju5.12543 |
Ejemplares similares
-
Editorial Comment on “Two cases of CRPC with BRCA mutation treated by olaparib after favorable response to cisplatin”
por: Hatano, Koji
Publicado: (2022) -
Retroperitoneal urothelial carcinoma arising after bladder diverticulectomy: a case report
por: Ohtsu, Akira, et al.
Publicado: (2023) -
Clinical endocrinological evaluation of the gonadal axis (testosterone, LH and FSH) in prostate cancer patients switched from a GnRH antagonist to a LHRH agonist
por: Miyazawa, Yoshiyuki, et al.
Publicado: (2015) -
Successful embolization of subcutaneous mesenteric varices within an ileal conduit in a patient with liver cirrhosis
por: Sakurai, Ayaka, et al.
Publicado: (2023) -
Ratio of the expression levels of androgen receptor splice variant 7 to androgen receptor in castration refractory prostate cancer
por: Sekine, Yoshitaka, et al.
Publicado: (2021)